Implementations by Phenotype

Title Phenotype Institution Algorithm Typesort ascending Total Cases Total Controls PPV Sensitivity
Marshfield C-diff implementation Clostridium Difficile Colitis Marshfield Clinic Research Foundation Case, Control 21 10 100%, 100%
appendicitis CHOP eMERGE III Appendicitis CHOP Case, Control
Vanderbilt Implementation- Adult- BioVU- Emerge subset Pneumonia- VUMC eMERGE v5.1 Vanderbilt University Medical Center Case, Control
Marshfield implementation CAAD (Carotid Artery Atherosclerosis Disease) Marshfield Clinic Research Foundation Case, Control 71 435 100%, 100% 100%
Group Health/University of Washington CAAD Implementation CAAD (Carotid Artery Atherosclerosis Disease) Group Health/University of Washington Case, Control 300 4,475 96%, 100%
Columbia - Hearing Loss Hearing Loss Columbia University Medical Center Case, Control 97 2,334
Marshfield implementation caMRSA Marshfield Clinic Research Foundation Case, Control 100%, 100% 100%, 100%
CHOP Type 1 Diabetes CHOP Case, Control
AAA Implementation - Columbia Abdominal Aortic Aneurysm ( AAA ) Columbia University Case, Control 10 1,354
CRS merged all sites CRS (Chronic Rhinosinusitis) Case, Control
CHOP Depression Depression Case, Control
CDiff Implementation - Columbia Clostridium Difficile Colitis Columbia University Case, Control 107 139
Harvard Implementation Appendicitis Case, Control 877 771
Columbia Implementation Pneumonia- VUMC eMERGE v5.1 Columbia University Case, Control 156 8,015 96%
Marshfield Implementation 2 CAAD (Carotid Artery Atherosclerosis Disease) Marshfield Clinic Research Foundation Case, Control 193 4,170 100%, 100%
Geisinger Implementation Hearing Loss Geisinger Case, Control 336 6,479
Geisinger caMRSA Implementation caMRSA Geisinger Case, Control 25 25 96%, 100% 96%
MGB Type 1 Diabetes Case, Control
Marshfield Venous Thromboembolism implementation Venous Thromboembolism (VTE) Marshfield Clinic Research Foundation Case, Control 50 49 98%, 100%
NU depression data Depression Northwestern University Case, Control
Geisinger c.Diff eMERGE3 Implementation Clostridium Difficile Colitis Geisinger Case, Control 20 20 100%, 100% 100%, 100%
GH/UW Implementation Appendicitis Case, Control 0 1,761
Marshfield Implementation Pneumonia- VUMC eMERGE v5.1 Marshfield Clinic Research Institute Case, Control
Mayo Clinic CAAD Evaluation CAAD (Carotid Artery Atherosclerosis Disease) Mayo Clinic Case, Control 100% 72%
Mayo clinic hearing loss implementation Hearing Loss Mayo Clinic Case, Control

Pages